Abstract
The present disclosure relates to a genetically modified microbial cell that includes a genetic modification resulting in the expression of a vanillate demethylase, where the microbial cell is capable of metabolizing at least one S-lignin decomposition molecule including at least one of syringate and/or 3-O-methyl gallate, and the genetically modified microbial cell is capable of producing gallate. In some embodiments of the present disclosure, the vanillate demethylase may include VanAB.
| Original language | American English |
|---|---|
| Patent number | 11,136,601 B2 |
| Filing date | 5/10/21 |
| State | Published - 2021 |
NLR Publication Number
- NREL/PT-2A00-81180
Keywords
- 3-O-methyl gallate
- molecule of syringate
- S-lignin decomposition
- vanillate demethylase